Table of Contents
Epidemiology Research International
Volume 2011 (2011), Article ID 698705, 8 pages
http://dx.doi.org/10.1155/2011/698705
Research Article

Dissemination and Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Collected in Puerto Rico Medical Center Hospitals during a 1-Year Period

1Department of Microbiology and Medical Zoology, School of Medicine, University of Puerto Rico, P.O. Box 365067, San Juan, PR 00936-5067, USA
2Department of Medical Microbiology, School of Medicine, Creighton University, Omaha, NE 68178, USA
3Department of Pathology and Laboratory Medicine, School of Medicine, University of Puerto Rico, San Juan, PR 00936-5067, USA

Received 25 August 2011; Revised 29 September 2011; Accepted 3 October 2011

Academic Editor: H. T. Sørensen

Copyright © 2011 Iraida E. Robledo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Bush, “Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae,” Current Opinion in Microbiology, vol. 13, no. 5, pp. 558–564, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Nordmann, G. Cuzon, and T. Naas, “The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria,” The Lancet Infectious Diseases, vol. 9, no. 4, pp. 228–236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Queenan and K. Bush, “Carbapenemases: the versatile β-lactamases,” Clinical Microbiology Reviews, vol. 20, no. 3, pp. 440–458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. P. E. Akpaka, W. H. Swanston, H. N. Ihemere et al., “Emergence of KPC-producing Pseudomonas aeruginosa in Trinidad and Tobago,” Journal of Clinical Microbiology, vol. 47, no. 8, pp. 2670–2671, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Poirel, P. Nordmann, E. Lagrutta, T. Cleary, and L. S. Munoz-Price, “Emergence of KPC-producing Pseudomonas aeruginosa in the United States,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 7, p. 3072, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. I. E. Robledo, E. E. Aquino, M. I. Sante et al., “Detection of KPC in Acinetobacter spp. in Puerto Rico,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 3, pp. 1354–1357, 2010. View at Publisher · View at Google Scholar
  7. I. E. Robledo, E. E. Aquino, and G. J. Vazquez, “Detection of the KPC gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 6, pp. 2968–2970, 2011. View at Publisher · View at Google Scholar
  8. M. V. Villegas, K. Lolans, A. Correa, J. N. Kattan, J. A. Lopez, and J. P. Quinn, “First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 4, pp. 1553–1555, 2007. View at Publisher · View at Google Scholar
  9. D. J. Wolter, N. Khalaf, I. E. Robledo et al., “Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican medical center hospitals: dissemination of KPC and IMP-18 β-lactamases,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 4, pp. 1660–1664, 2009. View at Publisher · View at Google Scholar
  10. C. J. Gregory, E. Llata, N. Stine et al., “Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant,” Infection Control and Hospital Epidemiology, vol. 31, no. 5, pp. 476–484, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Kassis-Chikhani, D. Decre, P. Ichai et al., “Outbreak of Klebsiella pneumoniae producing KPC-2 and SHV-12 in a French hospital,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 7, pp. 1539–1540, 2010. View at Publisher · View at Google Scholar
  12. K. Kontopoulou, E. Protonotariou, K. Vasilakos et al., “Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 β-lactamase resistant to colistin,” Journal of Hospital Infection, vol. 76, no. 1, pp. 70–73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Zhang, X. D. Wang, J. C. Cai et al., “Outbreak of KPC-2-producing Klebsiella pneumoniae with high qnr prevalence in a Chinese hospital,” Journal of Medical Microbiology, vol. 60, no. 11, part 7, pp. 977–982, 2011. View at Google Scholar
  14. A. Zioga, V. Miriagou, E. Tzelepi et al., “The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2,” International Journal of Antimicrobial Agents, vol. 36, no. 2, pp. 190–191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Curiao, M. I. Morosini, P. Ruiz-Garbajosa et al., “Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 8, pp. 1608–1614, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Naas, G. Cuzon, M. V. Villegas, M. F. Lartigue, J. P. Quinn, and P. Nordmann, “Genetic structures at the origin of acquisition of the β-lactamase bla KPC gene,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 4, pp. 1257–1263, 2008. View at Publisher · View at Google Scholar
  17. K. F. Anderson, D. R. Lonsway, J. K. Rasheed et al., “Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae,” Journal of Clinical Microbiology, vol. 45, no. 8, pp. 2723–2725, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement, vol. 30, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2010, Vol M100-S20.
  19. G. J. Vazquez, I. E. Robledo, A. Arroyo et al., “A comparison of the antimicrobial resistance patterns of gram-negative bacilli isolated from community-private and university-affiliated hospitals from Puerto Rico,” Puerto Rico Health Sciences Journal, vol. 22, no. 3, pp. 265–271, 2003. View at Google Scholar · View at Scopus
  20. E. S. Moland, N. D. Hanson, J. A. Black, A. Hossain, W. Song, and K. S. Thomson, “Prevalence of newer β-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002,” Journal of Clinical Microbiology, vol. 44, no. 9, pp. 3318–3324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. F. J. Perez-Perez and N. D. Hanson, “Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR,” Journal of Clinical Microbiology, vol. 40, no. 6, pp. 2153–2162, 2002. View at Publisher · View at Google Scholar
  22. J. D. Pitout, A. Hossain, and N. D. Hanson, “Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp,” Journal of Clinical Microbiology, vol. 42, no. 12, pp. 5715–5721, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. C. C. Sanders, W. E. Sanders Jr., and E. S. Moland, “Characterization of β-lactamases in situ on polyacrylamide gels,” Antimicrobial Agents and Chemotherapy, vol. 30, no. 6, pp. 951–952, 1986. View at Google Scholar
  24. R. V. Goering, “Pulsed field gel electrophoresis: a review of application and interpretation in the molecular epidemiology of infectious disease,” Infection, Genetics and Evolution, vol. 10, no. 7, pp. 866–875, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. R. V. Goering, “Pulsed-field gel electrophoresis,” in Molecular Microbiology: Diagnostic Principles and Practice, D. H. Persing, F. C. Tenover, J. Versalovic et al., Eds., pp. 185–196, ASM Press, Washington, DC, USA, 2004. View at Google Scholar
  26. D. J. Wolter, P. M. Kurpiel, N. Woodford, M. F. Palepou, R. V. Goering, and N. D. Hanson, “Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 2, pp. 557–562, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. E. S. Moland, G. H. Seong, K. S. Thomson, D. H. Larone, and N. D. Hanson, “Klebsiella pneumoniae isolate producing at least eight different β-lactamases, including AmpC and KPC β-lactamases,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 2, pp. 800–801, 2007. View at Publisher · View at Google Scholar
  28. M. Castanheira, H. S. Sader, and R. N. Jones, “Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae,” Microbial Drug Resistance, vol. 16, no. 1, pp. 61–65, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Alba, Y. Ishii, K. Thomson, E. S. Moland, and K. Yamaguchi, “Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing β-lactamase,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 11, pp. 4760–4762, 2005. View at Publisher · View at Google Scholar
  30. B. Kitchel, J. K. Rasheed, A. Endimiani et al., “Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 10, pp. 4201–4207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. A. L. Roth, P. M. Kurpiel, P. D. Lister, and N. D. Hanson, “blaKPC RNA expression correlates with two transcriptional start sites but not always with gene copy number in four genera of gram-negative pathogens,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 8, pp. 3936–3938, 2011. View at Publisher · View at Google Scholar
  32. A. Endimiani, F. Perez, S. Bajaksouzian et al., “Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility,” Journal of Clinical Microbiology, vol. 48, no. 12, pp. 4417–4425, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. Centers for Disease Control and Prevention (CDC), “Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities,” Morbidity and Mortality Weekly Report, vol. 58, no. 10, pp. 256–260, 2009. View at Google Scholar
  34. S. A. Clock, B. Cohen, M. Behta, B. Ross, and E. L. Larson, “Contact precautions for multidrug-resistant organisms: current recommendations and actual practice,” American Journal of Infection Control, vol. 38, no. 2, pp. 105–111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. J. Patel, A. Oshodi, P. Prasad et al., “Antibiotic use in neonatal intensive care units and adherence with centers for disease control and prevention 12 step campaign to prevent antimicrobial resistance,” Pediatric Infectious Disease Journal, vol. 28, no. 12, pp. 1047–1051, 2009. View at Publisher · View at Google Scholar · View at Scopus